This company has been acquired
Opiant Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Opiant Pharmaceuticals has a total shareholder equity of $20.5M and total debt of $13.8M, which brings its debt-to-equity ratio to 67.1%. Its total assets and total liabilities are $42.0M and $21.4M respectively.
Key information
67.1%
Debt to equity ratio
US$13.76m
Debt
| Interest coverage ratio | n/a |
| Cash | US$35.38m |
| Equity | US$20.50m |
| Total liabilities | US$21.45m |
| Total assets | US$41.95m |
Recent financial health updates
Recent updates
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Analysts Just Slashed This Year's Estimates
Aug 13
Opiant awarded additional $2.1M from BARDA for its nasal opioid overdose treatment
Aug 08Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Shares Could Be 47% Below Their Intrinsic Value Estimate
Aug 05Analysts Just Made A Major Revision To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Revenue Forecasts
Mar 21Opiant Pharmaceuticals (NASDAQ:OPNT) Is Posting Healthy Earnings, But It Is Not All Good News
Nov 19These 4 Measures Indicate That Opiant Pharmaceuticals (NASDAQ:OPNT) Is Using Debt Reasonably Well
Nov 17Opiant Pharmaceuticals: Assessing Recent Insider Buying
Sep 19Party Time: Brokers Just Made Major Increases To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Earnings Forecasts
Aug 07Increases to CEO Compensation Might Be Put On Hold For Now at Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT)
Jun 09The Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Yearly Results Are Out And Analysts Have Published New Forecasts
Mar 06News Flash: Analysts Just Made A Substantial Upgrade To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Forecasts
Mar 05Opiant Pharmaceuticals'(NASDAQ:OPNT) Share Price Is Down 41% Over The Past Three Years.
Jan 27Opiant Pharma secures additional BARDA grant of $3.5M for OPNT003
Dec 14Opiant Pharmaceuticals receives $50M in convertible debt financing
Dec 10Financial Position Analysis
Short Term Liabilities: OPNT's short term assets ($38.5M) exceed its short term liabilities ($7.0M).
Long Term Liabilities: OPNT's short term assets ($38.5M) exceed its long term liabilities ($14.4M).
Debt to Equity History and Analysis
Debt Level: OPNT has more cash than its total debt.
Reducing Debt: OPNT's debt to equity ratio has increased from 0% to 67.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OPNT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: OPNT has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 27.7% each year.